首页|miR-125b通过CDK14对上皮性卵巢癌细胞增殖和侵袭的影响

miR-125b通过CDK14对上皮性卵巢癌细胞增殖和侵袭的影响

扫码查看
目的 探讨miR-125b对CDK14 的靶向作用及其对上皮性卵巢癌(epithelial ovarian cancer,EOC)细胞增殖和侵袭的影响.方法 用RT-PCR法检测EOC细胞系(OVCAR3、HO8910、SKOV3)和人卵巢上皮细胞(HOSEpiC)中miR-125b的表达情况.用 CCK-8 法和菌落形成实验检测细胞增殖活性;细胞划痕试验和Transwell小室检测细胞迁移和侵袭能力.采用双荧光素酶报告基因分析方法验证miR-125b对CDK14 的靶向作用.结果 HOSEpiC 的miR-125b相对表达量明显高于EOC细胞系中的 3 种细胞(P<0.05).与对照组相比,用miR-125b干预EOC细胞系后,细胞的增殖、迁移和侵袭能力明显降低(P<0.05).用miR-125b inhibitor干预后,细胞的增殖、侵袭和迁移能力明显增强(P<0.05).与对照组相比,miR-125b过表达组的CDK14 表达更低(P<0.05),miR-125b inhibitor组的CDK14 表达更高(P<0.05),CDK14 过表达组的细胞增殖能力和侵袭能力更强(P<0.05).结论 miR-125b可通过靶向CDK14 而抑制EOC细胞的增殖和侵袭.
Effect of miR-125b on proliferation and invasion of epithelial ovarian cancer cells via CDK14
Objective To investigate the targeting effect of miR-125b on CDK14 and its effect on proliferation and invasion of epithelial ovarian cancer(EOC)cells.Methods RT-PCR was used to detect the expression of miR-125b in EOC cell lines(OVCAR3,HO8910,SKOV3)and human ovarian epithelial cells(HOSEpiC).CCK-8 assay and colony formation assay were used to detect cell proliferation activity,and cell scratch test and Transwell chamber were used to detect cell migration and invasion ability.Double luciferase reporter gene analysis was used to verify the targeting effect of miR-125b on CDK14.Results The relative expression of miR-125b in HOSEpiC was significantly higher than that in the three EOC cell lines(P<0.05).Compared with the control group,the proliferation,migration and invasion ability of EOC cell lines were significantly decreased after treatment with miR-125b(P<0.05).After intervention with miR-125b inhibitor,the proliferation,invasion and migration of cells were significantly enhanced(P<0.05).Compared with the control group,the expression of CDK14 in miR-125b overexpression group was lower(P<0.05),the expression of CDK14 in miR-125b inhibitor group was higher(P<0.05),the cell proliferation and invasion ability of CDK14 overexpression group was stronger(P<0.05).Conclusion miR-125b can inhibit the proliferation and invasion of EOC cells by targeting CDK14.

miR-125bCDK14epithelial ovarian cancerproliferationinvasionmigrationapoptosis

刘孟彬、张少华

展开 >

430050 湖北 武汉,武汉亚心总医院妇产科

miR-125b CDK14 上皮性卵巢癌 增殖 侵袭 迁移 凋亡

2024

中国计划生育和妇产科
中国医师协会 四川省医学情报研究所

中国计划生育和妇产科

CSTPCD
影响因子:1.116
ISSN:1674-4020
年,卷(期):2024.16(4)
  • 20